Basal cell carcinoma staging: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Basal cell carcinoma}}
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.
==Overview==
==Basal Cell Carcinoma Staging==
The American Joint Committee on Cancer (AJCC) stages basal cell carcinoma based on the TNM system:
T - tumor
N - lymph nodes
M - metastasis
The following table summarizes the '''T''' categories:
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''T Categories'''
| align="center" style="background:#f0f0f0;"|'''Description'''
|-
| '''Tis'''||Carcinoma in situ
|-
| '''T1'''||The tumor is blank 2 cm across AND has 0-1 high-risk features
|-
| '''T2'''||The tumor is  > 2 cm across AND has > 2 high-risk features
|-
| '''T3'''||The tumor has grown into facial bones
|-
| '''T4'''||The tumor has grown into other bones in the body or into the base of the skull
|}
The following table summarizes the '''N''' categories:
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''N categories'''
| align="center" style="background:#f0f0f0;"|'''Description'''
|-
| '''N0'''||The tumor has not spread to the lymph nodes
|-
| '''N1'''||The tumor has spread to 1 lymph node on the same side of the body as the main tumor AND is ≤ 3 cm across
|-
| '''N2a'''||The tumor has spread to 1 lymph node on the same side of the body as the main tumor AND is > 3 cm and ≤ 6 cm across
|-
| '''N2b'''||The tumor has spread to > 1 lymph node on the same side of the body as the main tumor AND is ≤ 6 cm across
|-
| '''N2c'''||The tumor has spread to > 1 lymph node on the other side of the body as the main tumor AND is ≤ 6 cm across
|-
| '''N3'''||The tumor has spread to any nearby lymph node AND is > 6 cm across
|}
The following table summarizes the '''M''' categories:
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''M categories'''
| align="center" style="background:#f0f0f0;"|'''Description'''
|-
| '''M0'''||The tumor has not spread to distant organs
|-
| '''M1'''||The tumor has spread to distant organs
|}
The T, N, and M categories are combined into stages. The following table summarizes the '''stage grouping'''.
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''Stage'''
| align="center" style="background:#f0f0f0;"|'''TNM Grouping'''
|-
| '''0'''||Tis, N0, M0
|-
| '''I'''||T1, N0, M0
|-
| '''II'''||T2, N0, M0
|-


{{Basal cell carcinoma}}
| '''III'''||T3, N0, M0; T1-T3, N1, M0
 
|-


Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
| '''IV'''||T1-T3, N2, M0; Any T, N3, M0; T4, any N, M0; Any T, any N, M1


|}
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Dermatology]]
[[Category:Dermatology]]

Revision as of 15:14, 24 July 2015

Basal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Basal Cell Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Basal cell carcinoma staging On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Basal cell carcinoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Basal cell carcinoma staging

CDC on Basal cell carcinoma staging

Basal cell carcinoma staging in the news

Blogs on Basal cell carcinoma staging

Directions to Hospitals Treating Basal cell carcinoma

Risk calculators and risk factors for Basal cell carcinoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.

Overview

Basal Cell Carcinoma Staging

The American Joint Committee on Cancer (AJCC) stages basal cell carcinoma based on the TNM system: T - tumor N - lymph nodes M - metastasis

The following table summarizes the T categories:

T Categories Description
Tis Carcinoma in situ
T1 The tumor is blank 2 cm across AND has 0-1 high-risk features
T2 The tumor is > 2 cm across AND has > 2 high-risk features
T3 The tumor has grown into facial bones
T4 The tumor has grown into other bones in the body or into the base of the skull

The following table summarizes the N categories:

N categories Description
N0 The tumor has not spread to the lymph nodes
N1 The tumor has spread to 1 lymph node on the same side of the body as the main tumor AND is ≤ 3 cm across
N2a The tumor has spread to 1 lymph node on the same side of the body as the main tumor AND is > 3 cm and ≤ 6 cm across
N2b The tumor has spread to > 1 lymph node on the same side of the body as the main tumor AND is ≤ 6 cm across
N2c The tumor has spread to > 1 lymph node on the other side of the body as the main tumor AND is ≤ 6 cm across
N3 The tumor has spread to any nearby lymph node AND is > 6 cm across

The following table summarizes the M categories:

M categories Description
M0 The tumor has not spread to distant organs
M1 The tumor has spread to distant organs

The T, N, and M categories are combined into stages. The following table summarizes the stage grouping.

Stage TNM Grouping
0 Tis, N0, M0
I T1, N0, M0
II T2, N0, M0
III T3, N0, M0; T1-T3, N1, M0
IV T1-T3, N2, M0; Any T, N3, M0; T4, any N, M0; Any T, any N, M1

References